Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bor15001l7 (2 trials)
docosanol (abreva) (1 trial)
Herpes Labialis (Phase 2)
Trials (2 total)
Trial APIs (2 total)